Journal
JOURNAL OF CLINICAL MICROBIOLOGY
Volume 55, Issue 8, Pages 2313-2320Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.00476-17
Keywords
infectious disease; lateral flow immunoassay; molecular diagnostic; point-of-care; rapid tests
Categories
Funding
- NIH [R33AI085548, R01AI093365, R41AI108114, R44AI109891, R43EB023408]
Ask authors/readers for more resources
Point-of-care (POC) diagnostics provide rapid actionable information for patient care at the time and site of an encounter with the health care system. The usual platform has been the lateral flow immunoassay. Recently, emerging molecular diagnostics have met requirements for speed, low cost, and ease of use for POC applications. A major driver for POC development is the ability to diagnose infectious diseases at sites with a limited infrastructure. The potential use in both wealthy and resource-limited settings has fueled an intense effort to build on existing technologies and to generate new technologies for the diagnosis of a broad spectrum of infectious diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available